AZGP1 and cholangiocarcinoma: A previous study on cholangiocarcinoma (CCA) identified TRIM25 as a negative regulator of AZGP1 and suggested that pathologically reduced AZGP1 may result from increased TRIM25 levels, since patients suffering from CCA were nearly deficient in AZGP1, but showed a high amount of TRIM25 [82].